Understanding how genetic differences affect antibody responses in diverse populations
An ethnically diverse genomic reference resource for the human heavy and light chain immunoglobulin loci
['FUNDING_OTHER'] · UNIVERSITY OF LOUISVILLE · NIH-10909931
This study is looking at how differences in our genes affect how our bodies make antibodies, which help us fight off illnesses like COVID-19 and autoimmune diseases, especially in people from diverse backgrounds who haven't been well studied before.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF LOUISVILLE (nih funded) |
| Locations | 1 site (LOUISVILLE, UNITED STATES) |
| Trial ID | NIH-10909931 on ClinicalTrials.gov |
What this research studies
This research investigates the genetic variations in the immunoglobulin heavy and light chain loci that influence how our bodies produce antibodies in response to health and disease. By focusing on diverse human populations, particularly those underrepresented in existing genomic resources, the study aims to fill gaps in our understanding of antibody responses. The researchers will analyze genetic data to explore how these variations impact immune responses, which could lead to better insights into diseases like COVID-19 and autoimmune disorders. This work involves advanced genomic techniques to assess the complexity of these genetic regions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals from diverse ethnic backgrounds, particularly those with autoimmune conditions or who have been affected by infectious diseases.
Not a fit: Patients who do not have a diverse genetic background or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immune responses, leading to improved treatments and vaccines for various diseases.
How similar studies have performed: Other research has shown success in understanding genetic diversity and its impact on immune responses, indicating that this approach is promising.
Where this research is happening
LOUISVILLE, UNITED STATES
- UNIVERSITY OF LOUISVILLE — LOUISVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WATSON, COREY TAYLOR — UNIVERSITY OF LOUISVILLE
- Study coordinator: WATSON, COREY TAYLOR
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus